CD86 and neoplasm: The combination of cisplatin and 5-fluorouracil also induced a significant release of HMGB1, DC maturation/activation, upregulation of CD80 and CD86 in tumor cell ICD response, and further enhancement of the host antitumor immune response with a favorable prognosis (72).